Sanofi Pasteur - Dengue


Dengue fever is a disease transmitted by the bite of the Aedes mosquito carrying one of the 4 dengue viruses. Each year, 390 million people are infected, of which 96 million people show clinical symptoms 1. An estimated 500,000 people with severe dengue require hospitalization each year, and about 2.5% of those affected die from dengue 1.

Sanofi Pasteur - Dengue - Global dengue burden, 2014
Sanofi Pasteur - Dengue - Dengue virus infection

Dengue virus infection

Watch the video
Sanofi Pasteur - Dengue - The Lingering Effect

The Lingering Effect

Watch the video
Sanofi Pasteur - Dengue - Key figures
Sanofi Pasteur - Dengue - Dengue infographics

Dengue infographics

Sanofi Pasteur - Dengue - Key figures
Sanofi Pasteur - Dengue - Symptoms and treatment

Vaccination against Dengue

In 2015, Sanofi Pasteur introduced the first dengue vaccine which is registered in several of the most endemic countries in the world. Implementation of public dengue vaccination programs should be consistent with current approved labelling for the first available dengue vaccine in each country where it is approved, as well as by updated WHO position for the vaccine as part of integrated dengue prevention efforts that include vector control, disease management and surveillance.


  1. WHO. Dengue and sever dengue. Fact sheet No 117. Updated April 2017. Accessed January 2018. Retrieved from:
  2. MG Guzman, E Harris, Dengue, The Lancet, Seminar, Volume 385, Issue 9966, Pages 453-465 (January 2015)